Gland Pharma Overview
- Year Founded
-
1978
- Status
-
Public
- Employees
-
3,999
- Stock Symbol
-
GLAND
- Investments
-
2
- Share Price
-
$35.46
- (As of Friday Closing)
Gland Pharma General Information
Description
Gland Pharma Ltd is engaged in manufacturing injectable formulations. It has presence in USA, India, Europe, Canada, Australia, New Zealand, and Rest of World. The company generates majority of revenue from USA.
Contact Information
Website
www.glandpharma.comCorporate Office
- Plot Number 11 & 84, TSIIC Phase: IV Pashamylaram (V)
- Patancheru (M), Sangareddy District
- Hyderabad, Telangana 502307
- India
Corporate Office
- Plot Number 11 & 84, TSIIC Phase: IV Pashamylaram (V)
- Patancheru (M), Sangareddy District
- Hyderabad, Telangana 502307
- India
Gland Pharma Stock Performance
As of 13-Nov-2026, Gland Pharma’s stock price is $35.46. Its current market cap is $5.85B with 165M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $35.46 | $35.31 | $16.99 - $35.92 | $5.85B | 165M | 491K | $0.81 |
Gland Pharma Financials Summary
As of 30-Sep-2026, Gland Pharma has a trailing 12-month revenue of $763M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 4,660,822 | 2,642,341 | 2,757,681 | 3,423,631 |
| Revenue | 762,736 | 724,607 | 660,337 | 681,485 |
| EBITDA | 237,478 | 193,774 | 150,626 | 162,865 |
| Net Income | 133,291 | 116,260 | 82,610 | 93,308 |
| Total Assets | 1,345,818 | 1,325,967 | 1,312,253 | 1,278,426 |
| Total Debt | 26,151 | 30,056 | 36,677 | 44,628 |
Gland Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Gland Pharma Comparisons
Industry
Financing
Details
Gland Pharma Competitors (7)
One of Gland Pharma’s 7 competitors is Natco Pharma, a Corporation company based in Hyderabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Natco Pharma | Corporation | Hyderabad, India | ||||
| Emcure Pharmaceuticals | Formerly PE-Backed | Pune, India | ||||
| Maiva Pharma | Private Equity-Backed | Krishnagiri, India | ||||
| Lupin | Corporation | Mumbai, India | ||||
| Neuland Laboratories | Corporation | Hyderabad, India |
Gland Pharma Patents
Gland Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190295732-A1 | Apparatus for predicting outbreak of avian influenza | Inactive | 21-Mar-2018 | ||
| WO-2018216827-A1 | Device and method related to earthquake shock mitigation | Inactive | 23-May-2017 | ||
| WO-2017118885-A1 | Stable pharmacuetical compositions of calcitriol | Inactive | 04-Jan-2016 | ||
| US-20180079669-A1 | Method for selection of appropriate location to reduce the atmospheric carbon dioxide through large-scale iron fertilization with less accumulation rate of volcanic sulfur compounds | Inactive | 23-Jul-2015 | ||
| WO-2017014341-A2 | Method for selection of appropriate location to reduce the atmospheric carbon dioxide through large-scale iron fertilization with less accumulation rate of volcanic sulfur compounds | Inactive | 23-Jul-2015 | B01D53/62 |
Gland Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Gland Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Gland Pharma Investments & Acquisitions (2)
Gland Pharma’s most recent deal was a Merger/Acquisition with Cenexi for . The deal was made on 27-Apr-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cenexi | 27-Apr-2023 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Vitane Biologics (Equipment and Facility) | 19-May-2021 | Corporate Asset Purchase | Buildings and Property |
Gland Pharma ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
30.8 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Gland Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cenexi | Fontenay-Sous-Bois, France | 2004 |
Gland Pharma FAQs
-
When was Gland Pharma founded?
Gland Pharma was founded in 1978.
-
Where is Gland Pharma headquartered?
Gland Pharma is headquartered in Hyderabad, India.
-
What is the size of Gland Pharma?
Gland Pharma has 3,999 total employees.
-
What industry is Gland Pharma in?
Gland Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Gland Pharma a private or public company?
Gland Pharma is a Public company.
-
What is Gland Pharma’s stock symbol?
The ticker symbol for Gland Pharma is GLAND.
-
What is the current stock price of Gland Pharma?
As of 13-Nov-2026 the stock price of Gland Pharma is $35.46.
-
What is the current market cap of Gland Pharma?
The current market capitalization of Gland Pharma is $5.85B.
-
What is Gland Pharma’s current revenue?
The trailing twelve month revenue for Gland Pharma is $763M.
-
Who are Gland Pharma’s competitors?
Natco Pharma, Emcure Pharmaceuticals, Maiva Pharma, Lupin, and Neuland Laboratories are some of the 7 competitors of Gland Pharma.
-
What is Gland Pharma’s annual earnings per share (EPS)?
Gland Pharma’s EPS for 12 months was $0.81.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
